A team of Brown University researchers has used a brain-computer interface to reconstruct English words from neural signals recorded in the brains of nonhuman primates. The research, published in the journal Nature Communications ...
Dec 13, 2019
1
214
Michelangelo reportedly said the job of every sculptor is to discover the statue inside the stone, then work around it. Liberate the form.
Dec 13, 2019
0
145
When the immune system detects a foreign pathogen, a cascade of chemical signals call white blood cells to the scene. Neutrophils are the most common and abundant type of these cells and while they start accumulating at the ...
Dec 13, 2019
0
21
The brain determines when it is time to feed—but how does it know? Findings from St. Jude Children's Research Hospital provide new understanding of how the brain orchestrates this process. Skeletal muscle, like other tissues, ...
Dec 13, 2019
0
267
Children in low- and middle-income countries (LMICs) are receiving an average of 25 antibiotic prescriptions during their first five years of life, an excessive amount that could harm the children's ability to fight pathogens ...
Dec 13, 2019
0
57
Myths about healthy water drinking may be putting older people's health at risk by discouraging them from drinking enough fluid to stay healthy, according to a new UCL-led study.
Dec 13, 2019
1
461
U.S. health regulators approved a second drug for a debilitating form of muscular dystrophy, a surprise decision after the medication was rejected for safety concerns just four months ago.
Dec 13, 2019
0
369
While trying to develop a comparatively easy, inexpensive way to give physicians and their patients with bladder cancer a better idea of likely outcome and best treatment options, scientists found that sophisticated new subtyping ...
Dec 13, 2019
0
35
Researchers at the Icahn School of Medicine at Mount Sinai have identified novel genes associated with the severity of peanut allergy, as well as ways in which these genes interact with other genes during allergic reactions.
Dec 13, 2019
0
11
Pooled analysis of three phase 1 and 2 clinical trials published online ahead of print in the journal Lancet Oncology show that the drug entrectinib is effective and well-tolerated against advanced ROS1 and NTRK fusion-positive ...
Dec 13, 2019
0
12
